CIMETIDINE CLEARANCE IN THE OBESE

被引：25

作者：

BAUER, LA

WAREINGTRAN, C

EDWARDS, WAD

RAISYS, V

FERRERI, L

JACK, R

DELLINGER, EP

SIMONOWITZ, D

机构：

[1] UNIV WASHINGTON,SCH MED,DEPT LAB MED,SEATTLE,WA 98195

[2] UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 37卷 / 04期

关键词：

D O I：

10.1038/clpt.1985.66

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：425 / 430

页数：6

共 26 条

[1]

ABERNETHY DR, 1984, AM J GASTROENTEROL, V79, P91

[2]

ALEXANDER J K, 1962, Cardiovasc Res Cent Bull, V1, P39

[3] AMIKACIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS [J].

BAUER, LA ;

BLOUIN, RA ;

GRIFFEN, WO ;

RECORD, KE ;

BELL, RM .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (04) :519-522

[4] INFLUENCE OF WEIGHT ON AMINOGLYCOSIDE PHARMACOKINETICS IN NORMAL WEIGHT AND MORBIDLY OBESE PATIENTS [J].

BAUER, LA ;

EDWARDS, WAD ;

DELLINGER, EP ;

SIMONOWITZ, DA .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (05) :643-647

[5] TOBRAMYCIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS [J].

BLOUIN, RA ;

MANN, HJ ;

GRIFFEN, WO ;

BAUER, LA ;

RECORD, KE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :508-512

[6] VANCOMYCIN PHARMACOKINETICS IN NORMAL AND MORBIDLY OBESE SUBJECTS [J].

BLOUIN, RA ;

BAUER, LA ;

MILLER, DD ;

RECORD, KE ;

GRIFFEN, WO .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) :575-580

[7] PHARMACOKINETICS OF CIMETIDINE AFTER SINGLE DOSES AND DURING CONTINUOUS TREATMENT [J].

BODEMAR, G ;

NORLANDER, B ;

WALAN, A .

CLINICAL PHARMACOKINETICS, 1981, 6 (04) :306-315

[8]

BODEMAR G, 1977, 2ND P INT S HIST H2, P224

[9] PHARMACOLOGICAL EVALUATION OF CIMETIDINE, A NEW HISTAMINE H2-RECEPTOR ANTAGONIST, IN HEALTHY MAN [J].

BURLAND, WL ;

DUNCAN, WAM ;

HESSELBO, T ;

MILLS, JG ;

SHARPE, PC ;

HAGGIE, SJ ;

WYLLIE, JH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (06) :481-486

[10]

DEDRICK RL, 1980, FED PROC, V39, P54

← 1 2 3 →